Abstract

Arterial axillosubclavian injuries (ASIs) are currently managed with open repair (OR) and endovascular stenting (ES). The long-term prognosis of patients with these and associated brachial plexus injuries is poorly understood. We hypothesize that OR and ES for ASI have similar long-term patency rates and that brachial plexus injuries would confer high long-term morbidity. All patients at a level-1 trauma center who underwent procedures for ASI over a 12-year period (2010 to 2022) were identified. Long-term outcomes of patency rates, types of reintervention, rates of brachial plexus injury, and functional outcomes were then investigated. Thirty-three patients underwent operations for ASI. OR was performed in 72.7% (n=24) and ES in 27.3% (n=9). ES patency was 85.7% (n=6/7) and OR patency was 75% (n=12/16), at a median follow-up of 20 and 5.5months respectively. In subclavian artery injuries, ES patency was 100% (n=4/4) and OR patency was 50% (n=4/8) at a median follow-up of 24 and 12months respectively. Long-term patency rates were similar between OR and ES (P=1.0). Brachial plexus injuries occurred in 42.9% (n=12/28) of patients. Ninety percent (n=9/10) of patients with brachial plexus injuries who were followed postdischarge had persistent motor deficits at median follow-up of 12months, occurring at significantly higher rates in patients with brachial plexus injuries (90%) compared to those without brachial plexus injuries (14.3%) (P=0.0005). Multiyear follow-up demonstrates similar OR and ES patency rates for ASI. Subclavian ES patency was excellent (100%) and prosthetic subclavian bypass patency was poor (25%). brachial plexus injuries were common (42.9%) and devastating, with a significant portion of patients having persistent limb motor deficits (45.8%) on long-term follow-up. Algorithms to optimize brachial plexus injuries management for patients with ASI are high-yield, and likely to influence long-term outcomes more than the technique of initial revascularization.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call